FDA Proposes First New Sunscreen Active Ingredient in 25 Years
Summary
Wiley Rein LLP's inaugural Rules and Reactions podcast episode discusses the FDA's proposal to approve the first new active sunscreen ingredient in over 25 years. Hosted by Lauren Petrin and Dr. Alex Stanton, the episode examines how sunscreens are regulated as OTC drugs in the United States and explores what this historic regulatory shift could mean for future product innovation in the industry.
“The inaugural episode shines a light on sunscreen – and the FDA's recent proposal to add the first new active ingredient in over 25 years.”
About this source
GovPing monitors JD Supra Healthcare for new healthcare & life sciences regulatory changes. Every update since tracking began is archived, classified, and available as free RSS or email alerts — 248 changes logged to date.
What changed
This document is a podcast episode description from Wiley Rein LLP's Environmental and FDA Regulatory practices discussing the FDA's proposal to add the first new active sunscreen ingredient in more than 25 years. The inaugural Rules and Reactions episode provides an overview of sunscreen regulation as OTC drugs under FDA oversight and examines the potential implications of this development for future product innovation in the sunscreen industry.
Sunscreen manufacturers and pharmaceutical companies producing OTC sunscreen products should monitor FDA's progress on this proposed new active ingredient. If approved, it would represent a significant change in the available regulatory pathway for innovative sunscreen formulations in the U.S. market, potentially aligning U.S. standards more closely with international markets.
Archived snapshot
Apr 22, 2026GovPing captured this document from the original source. If the source has since changed or been removed, this is the text as it existed at that time.
April 22, 2026
[Podcast] FDA Gives Rise to a New Era in Sunscreen Regulation
Lauren Petrin, Alex L. D. Stanton Wiley Rein LLP + Follow Contact LinkedIn Facebook X ;) Embed
Welcome to Rules and Reactions, a joint podcast from Wiley’s Environmental and FDA Regulatory practices. Hosted by Lauren Petrin and Dr. Alex Stanton, the podcast combines legal and scientific perspectives on evolving federal and state regulations that are shaping innovation in environmental policy and FDA-regulated industries. The inaugural episode shines a light on sunscreen – and the FDA’s recent proposal to add the first new active ingredient in over 25 years. We break down how the product is regulated in the United States and what this historic shift could mean for future innovation.
;) ;) Report
Latest Posts
- [Podcast] FDA Gives Rise to a New Era in Sunscreen Regulation
- Illinois Federal Court Holds CGL Policy Does Not Cover Remediation Costs for Illegal Dumping
- Congress Again Approaches Deadline for Extending FISA 702 Authorities, Creating Uncertainty for Communications Providers
- DOJ’s Recent Statements Reflect Consistent Focus, Balanced Approach to Antitrust and IP Enforcement
- How India and the U.S. Are Redefining Global Trade Rules See more »
DISCLAIMER: Because of the generality of this update, the information provided herein may not be applicable in all situations and should not be acted upon without specific legal advice based on particular situations.
Attorney Advertising.
©
Wiley Rein LLP
Written by:
Wiley Rein LLP Contact + Follow Lauren Petrin + Follow Alex L. D. Stanton + Follow more less
PUBLISH YOUR CONTENT ON JD SUPRA
- ✔ Increased readership
- ✔ Actionable analytics
- ✔ Ongoing writing guidance Join more than 70,000 authors publishing their insights on JD Supra
Published In:
Food and Drug Administration (FDA) + Follow Innovation + Follow New Regulations + Follow Proposed Rules + Follow Regulatory Oversight + Follow Regulatory Requirements + Follow Rulemaking Process + Follow Administrative Agency + Follow Environmental + Follow Health + Follow more less
Wiley Rein LLP on:
"My best business intelligence, in one easy email…"
Your first step to building a free, personalized, morning email brief covering pertinent authors and topics on JD Supra: Sign Up Log in ** By using the service, you signify your acceptance of JD Supra's Privacy Policy.* - hide - hide
Mentioned entities
Related changes
Get daily alerts for JD Supra Healthcare
Daily digest delivered to your inbox.
Free. Unsubscribe anytime.
Source
About this page
Every important government, regulator, and court update from around the world. One place. Real-time. Free. Our mission
Source document text, dates, docket IDs, and authority are extracted directly from Wiley Rein.
The summary, classification, recommended actions, deadlines, and penalty information are AI-generated from the original text and may contain errors. Always verify against the source document.
Classification
Who this affects
Taxonomy
Browse Categories
Get alerts for this source
We'll email you when JD Supra Healthcare publishes new changes.
Subscribed!
Optional. Filters your digest to exactly the updates that matter to you.